User profiles for Zev A. Binder

Zev A. Binder

University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Cited by 3525

The genetic landscape of the childhood cancer medulloblastoma

…, C Bettegowda, GL Gallia, GI Jallo, ZA Binder… - science, 2011 - science.org
Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the
genetic alterations in this tumor type, we searched for copy number alterations using high-…

[PDF][PDF] A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity

…, T Lucas, HI Chen, JF Dorsey, KM Christian, ZA Binder… - Cell, 2020 - cell.com
Glioblastomas exhibit vast inter- and intra-tumoral heterogeneity, complicating the development
of effective therapeutic strategies. Current in vitro models are limited in preserving the …

[HTML][HTML] Long interspersed element-1 protein expression is a hallmark of many human cancers

…, TL Lotan, AM De Marzo, W Westra, ZA Binder… - The American journal of …, 2014 - Elsevier
Cancers comprise a heterogeneous group of human diseases. Unifying characteristics
include unchecked abilities of tumor cells to proliferate and spread anatomically, and the …

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

…, H Song, DL Siegel, CH June, EO Hexner, ZA Binder… - Nature Medicine, 2024 - nature.com
Recurrent glioblastoma (rGBM) remains a major unmet medical need, with a median overall
survival of less than 1 year. Here we report the first six patients with rGBM treated in a phase …

[PDF][PDF] Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development

ZA Binder, AH Thorne, S Bakas, EP Wileyto, M Bilello… - Cancer cell, 2018 - cell.com
We explored the clinical and pathological impact of epidermal growth factor receptor (EGFR)
extracellular domain missense mutations. Retrospective assessment of 260 de novo …

[HTML][HTML] Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond …

…, M Rozycki, KG Abdullah, MLP Nasrallah, ZA Binder… - Scientific reports, 2018 - nature.com
The remarkable heterogeneity of glioblastoma, across patients and over time, is one of the
main challenges in precision diagnostics and treatment planning. Non-invasive in vivo …

[HTML][HTML] The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics

…, W Parker, J Doshi, U Baid, M Bergman, ZA Binder… - Scientific data, 2022 - nature.com
Glioblastoma is the most common aggressive adult brain tumor. Numerous studies have
reported results from either private institutional data or publicly available datasets. However, …

[HTML][HTML] Checkpoint blockade reverses anergy in IL-13Rα2 humanized scFv-based CAR T cells to treat murine and canine gliomas

Y Yin, AC Boesteanu, ZA Binder, C Xu, RA Reid… - Molecular Therapy …, 2018 - cell.com
We generated two humanized interleukin-13 receptor α2 (IL-13Rα2) chimeric antigen
receptors (CARs), Hu07BBz and Hu08BBz, that recognized human IL-13Rα2, but not IL-13Rα1. …

[PDF][PDF] Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides

…, A Merlotti, M Carrascal, JV Zhang, E Zueva, ZA Binder… - Cell Reports, 2022 - cell.com
We analyze transposable elements (TEs) in glioblastoma (GBM) patients using a
proteogenomic pipeline that combines single-cell transcriptomics, bulk RNA sequencing (RNA-seq) …

Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma

…, D Zhang, M Huang, L Zhang, JF Dorsey, ZA Binder… - Nature cancer, 2021 - nature.com
Malignant solid tumors are characterized by aberrant vascularity that fuels the formation of
an immune-hostile microenvironment and induces resistance to immunotherapy. Vascular …